Crystallographic Studies of Prion Protein (PrP) Segments Suggest How Structural Changes Encoded by Polymorphism at Residue 129 Modulate Susceptibility to Human Prion Disease*

A single nucleotide polymorphism (SNP) in codon 129 of the human prion gene, leading to a change from methionine to valine at residue 129 of prion protein (PrP), has been shown to be a determinant in the susceptibility to prion disease. However, the molecular basis of this effect remains unexplained. In the current study, we determined crystal structures of prion segments having either Met or Val at residue 129. These 6-residue segments of PrP centered on residue 129 are “steric zippers,” pairs of interacting β-sheets. Both structures of these “homozygous steric zippers” reveal direct intermolecular interactions between Met or Val in one sheet and the identical residue in the mating sheet. These two structures, plus a structure-based model of the heterozygous Met-Val steric zipper, suggest an explanation for the previously observed effects of this locus on prion disease susceptibility and progression.

[1]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[2]  W. Surewicz,et al.  Conformational diversity in prion protein variants influences intermolecular β‐sheet formation , 2010, The EMBO journal.

[3]  C. Soto,et al.  Biochemical and structural studies of the prion protein polymorphism , 2001, FEBS letters.

[4]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[5]  A. Ghani,et al.  Updated projections of future vCJD deaths in the UK , 2003 .

[6]  P. Bayley,et al.  The crystal structure of the globular domain of sheep prion protein. , 2004, Journal of molecular biology.

[7]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[8]  David Eisenberg,et al.  Molecular mechanisms for protein-encoded inheritance , 2009, Nature Structural &Molecular Biology.

[9]  David Eisenberg,et al.  Molecular basis for insulin fibril assembly , 2009, Proceedings of the National Academy of Sciences.

[10]  Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. , 2005 .

[11]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[12]  S. Mead,et al.  Prion disease genetics , 2006, European Journal of Human Genetics.

[13]  K Wüthrich,et al.  Prion protein NMR structure and familial human spongiform encephalopathies. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[15]  J. Collinge,et al.  Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. , 2006, The Journal of general virology.

[16]  A. Alpérovitch,et al.  Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease , 1999, The Lancet.

[17]  R. Diaz-Avalos,et al.  Protein-only transmission of three yeast prion strains , 2004, Nature.

[18]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[19]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[20]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[21]  J. Fontecilla-Camps,et al.  Contaminant effects on protein crystal morphology in different growth environments. , 1996, Acta Crystallographica Section D: Biological Crystallography.

[22]  Jonathan S. Weissman,et al.  The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.

[23]  S. Lindquist,et al.  Nucleated conformational conversion and the replication of conformational information by a prion determinant. , 2000, Science.

[24]  David W. Colby,et al.  Natural and synthetic prion structure from X-ray fiber diffraction , 2009, Proceedings of the National Academy of Sciences.

[25]  J R Glover,et al.  Support for the Prion Hypothesis for Inheritance of a Phenotypic Trait in Yeast , 1996, Science.

[26]  F. Cohen,et al.  X-ray diffraction of scrapie prion rods and PrP peptides. , 1995, Journal of molecular biology.

[27]  Bosco K. Ho,et al.  HOLLOW: Generating Accurate Representations of Channel and Interior Surfaces in Molecular Structures , 2008, BMC Structural Biology.

[28]  John Collinge,et al.  A General Model of Prion Strains and Their Pathogenicity , 2007, Science.

[29]  E. M. Jones,et al.  Role of N-terminal Familial Mutations in Prion Protein Fibrillization and Prion Amyloid Propagation in Vitro*♦ , 2006, Journal of Biological Chemistry.

[30]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[31]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[32]  M. Saraste,et al.  FEBS Lett , 2000 .

[33]  R. Wickner,et al.  [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. , 1994, Science.

[34]  S. Prusiner,et al.  Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.

[35]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.

[36]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[37]  John Collinge,et al.  Kuru in the 21st century—an acquired human prion disease with very long incubation periods , 2006, The Lancet.

[38]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[39]  P. Lansbury,et al.  Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. , 1992, Biochemistry.

[40]  L. Breydo,et al.  The presence of valine at residue 129 in human prion protein accelerates amyloid formation , 2005, FEBS letters.

[41]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[42]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.

[43]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[44]  D. Hall,et al.  Silent prions lying in wait: a two-hit model of prion/amyloid formation and infection. , 2004, Journal of molecular biology.

[45]  Peter Rudge,et al.  Variant CJD in an individual heterozygous for PRNP codon 129 , 2009, The Lancet.

[46]  David Eisenberg,et al.  Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.

[47]  David Eisenberg,et al.  Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.

[48]  B. Ghetti,et al.  A new PRNP mutation (G131V) associated with Gerstmann-Sträussler-Scheinker disease. , 2001, Archives of neurology.

[49]  Michael P H Stumpf,et al.  Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics , 2003, Science.

[50]  J. Collinge,et al.  The Residue 129 Polymorphism in Human Prion Protein Does Not Confer Susceptibility to Creutzfeldt-Jakob Disease by Altering the Structure or Global Stability of PrPC* , 2004, Journal of Biological Chemistry.

[51]  S. Lindquist,et al.  Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI +], a Heritable Prion-like Factor of S. cerevisiae , 1997, Cell.

[52]  John Collinge,et al.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease , 1991, Nature.

[53]  Y. Agid,et al.  Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK , 2003, The Lancet.